NDC11 24201010104
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 24201-0101-04 | 24201-0101 |
| 24201-0101-4 | 24201-0101 |
| 24201-101-04 | 24201-101 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valrubicin Intravesical Solution | VALRUBICIN INTRAVESICAL SOLUTION | Hikma Pharmaceuticals USA Inc. | 8739ae02-e4c5-0fa2-e053-2a91aa0a1b74 | 2022-06-30 | Warnings, Adverse reactions | 24201-101-04 24201-101 24201010104 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.